Federal Register of Legislation - Australian Government

Primary content

PB 61 of 2020 Determinations/Health as made
This instrument amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010) to add one drug to F1. In addition it removes one drug from F1 as this drug is no longer PBS listed.
Administered by: Health
Registered 30 Jun 2020

 

PB 61 of 2020

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated    29   June 2020

 

 

 

 

 

 

 

 

 

THEA DANIEL

 

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2020 (No. 6).

         (2)   This Determination may also be cited as PB 61 of 2020.

2              Commencement

                This Determination commences on 1 July 2020.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

[1]     Schedule 1, after item dealing with Pralatrexate

 

Omit

Prasugrel

 

[2]     Schedule 1, after item dealing with Secukinumab

 

Insert

Semaglutide